Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (141-150 of 259) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritisNathalie Busso, Alexander So, Véronique Chobaz-Péclat, et al.
Arthritis Research & Therapy|November 6, 2012
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same diseaseSebastien Viatte, Edward Flynn, Mark Lunt, et al.
Arthritis and Rheumatism|May 1, 2007
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agentsAxel Finckh, Adrian Ciurea, Laure Brulhart, et al.
RMD Open|September 29, 2017
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trialsVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Arthritis and Rheumatism|April 18, 2012
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatmentsFabien Dépis, Eric Hatterer, Céline Lamacchia, et al.
Annals of the Rheumatic Diseases|November 11, 2011
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in miceCéline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memoryClaudia Zimmerli, Boris P L Lee, Gaby Palmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2016
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJennifer Palomo, Beatris Mastelic-Gavillet, Estelle Woldt, et al.
Arthritis Research & Therapy|June 7, 2015
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyLara Fischer, Patricia Francis Gerstel, Antoine Poncet, et al.
Arthritis and Rheumatism|July 9, 2011
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritisJean-Marc Waldburger, Gaby Palmer, Christian Seemayer, et al.
Pageof 26

Showing results (141-150 of 259) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritisNathalie Busso, Alexander So, Véronique Chobaz-Péclat, et al.
Arthritis Research & Therapy|November 6, 2012
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same diseaseSebastien Viatte, Edward Flynn, Mark Lunt, et al.
Arthritis and Rheumatism|May 1, 2007
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agentsAxel Finckh, Adrian Ciurea, Laure Brulhart, et al.
RMD Open|September 29, 2017
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trialsVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Arthritis and Rheumatism|April 18, 2012
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatmentsFabien Dépis, Eric Hatterer, Céline Lamacchia, et al.
Annals of the Rheumatic Diseases|November 11, 2011
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in miceCéline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memoryClaudia Zimmerli, Boris P L Lee, Gaby Palmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2016
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJennifer Palomo, Beatris Mastelic-Gavillet, Estelle Woldt, et al.
Arthritis Research & Therapy|June 7, 2015
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyLara Fischer, Patricia Francis Gerstel, Antoine Poncet, et al.
Arthritis and Rheumatism|July 9, 2011
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritisJean-Marc Waldburger, Gaby Palmer, Christian Seemayer, et al.
Pageof 26